MARY OGDEN: Open Payments
NPI 1043392715 · CHATTANOOGA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$357 in 20 payments from 7 companies in 2025. Trend: 2023 $203 · 2024 $395 · 2025 $357
Food & beverage: $356Education: $2
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 9 | $169 |
| Travere Therapeutics, Inc. | 6 | $85 |
| Novartis Pharmaceuticals Corporation | 1 | $27 |
| Calliditas Therapeutics US Inc. | 1 | $22 |
| Apellis Pharmaceuticals, Inc. | 1 | $19 |
| Xeris Pharmaceuticals, Inc. | 1 | $18 |
| KYOWA KIRIN, INC. | 1 | $17 |
Products named: JYNARQUE, VOYXACT, Fabhalta, TARPEYO, Empaveli, KEVEYIS, CRYSVITA, Filspari.
Industry payments across TN — which companies pay providers there.
